Clinical trials: Neonatal Hyperbilirubinemia
Crigler-Najjar Syndrome
Clinical Assessment Study in Crigler-Najjar Syndrome
This is a Pre-Phase 1 prospective, non-interventional clinical assessment study to evaluate Crigler-Najjar syndrome subjects requiring daily phototherapy, aged 1 year and older.
- Trial name
- LUSTRO (NCT03078881)
- Where
- 4 sites in United States, Israel and 1 more
- Volunteers
- 8 people
- Sponsor
- Audentes Therapeutics
Jaundice and Sepsis in Neonates
Ceftriaxone and Jaundice in Neonates
Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week.
- Trial name
- CEFT (NCT03133637)
- Testing
- ceftriaxone
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- University of Rochester
Neonatal Hyperbilirubinemia
Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life
The Shoklo Malaria Research Unit (SMRU) provides care to refugees and migrant populations along the Thai-Burma border since 1986.
- Trial name
- NCT02927093
- Volunteers
- 78 people
- Sponsor
- University of Oxford
Neonatal Jaundice, Phototherapy Complication
Continuous Versus Intermittent Phototherapy in Treatment of Neonatal Jaundice
One of the most common diseases in the neonatal period is indirect hyperbilirubinemia (IHB). After phototherapy was discovered accidentally in 1958, it has been used as the most effective treatment method for IHD for more than 60…
- Trial name
- NCT06386731
- Testing
- Intermittent Phototherapy
- Where
- Turkey (Türkiye)
- Volunteers
- 225 people
- Sponsor
- Goztepe Prof Dr Suleyman Yalcın City Hospital
Prematurity, Neonatal Encephalopathy
Evaluating the NeoTree in Malawi and Zimbabwe
Neonatal mortality remains unacceptably high. Globally, the majority of mothers now deliver in health facilities in low resource settings where quality of newborn care is poor.
- Conditions
- Prematurity, Neonatal Encephalopathy, Neonatal Sepsis, Neonatal Death
- Trial name
- NCT05127070
- Testing
- Neotree
- Where
- 5 sites in Malawi, Zimbabwe
- Volunteers
- 19,000 people
- Sponsor
- University College, London
Hyperbilirubinemia, Neonatal
Bundling Gentle Body Massage Along With Regular Position Change Under Phototherapy
This study aimed to investigate the effect of bundling gentle body massage along with regular position change on bilirubin level and clinical outcomes among full-term neonates with hyperbilirubinemia under phototherapy.
- Trial name
- NCT05260138
- Testing
- Gentle Body message, Routine NICU Care
- Where
- Egypt
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Alexandria University
Neonatal Cholestasis, Neonatal Jaundice
Liver Biopsy in Diagnosis Neonatal Jaundice
1. Identification and characterization of histopathological features of liver in cases of PNJ. 2. Assessment of key histological features in liver biopsy as diagnostic parameters in differentiating intra-hepatic and extra-hepatic…
- Trial name
- NCT06628726
- Testing
- Liver biopsy
- Volunteers
- 50 people
- Sponsor
- Assiut University
Newborn Jaundice
Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm
Due to actual standard of neonatal care bilirubin is monitored in neonates several times after birth to avoid hyperbilirubinemia.
- Trial name
- Bili-PrediX1 (NCT05121311)
- Testing
- NeoprediX B1 algorithm
- Where
- 2 sites in Germany
- Volunteers
- 455 people
- Sponsor
- NeoPredix AG
Neonatal Jaundice
Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial
The purpose of this study is to determine the effect of 10 mg of oral zinc given daily between days 2 and 7 of life to term or near term neonates with serum bilirubin levels of more than 6 mg/dL at 24 ± 6 hours of life on…
- Trial name
- NCT00692224
- Testing
- zinc gluconate
- Where
- India
- Volunteers
- 294 people
- Sponsor
- All India Institute of Medical Sciences
Neonatal Hyperbilirubinemia
Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)
Background: Neonatal hyperbilirubinemia is the most common reason for admission in the neonatal period (first month of life) worldwide and at SMRU.
- Trial name
- NCT02361788
- Where
- Thailand
- Volunteers
- 1,710 people, healthy volunteers welcome
- Sponsor
- University of Oxford